Terns Pharmaceuticals Ratios (2020-2025) | TERN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Efficiency
Assets Average (Quarter)					145.77M	193.62M	183.95M	173.98M	162.37M	150.76M	168.72M	239.81M	294.16M	295.49M	280.69M	270.10M	257.64M	238.82M	304.56M	371.08M	351.62M	329.87M	311.03M	663.36M
Equity Average (Quarter)					36.28M	185.67M	176.74M	166.23M	154.51M	142.97M	160.46M	230.32M	282.31M	280.92M	266.29M	256.90M	246.04M	227.70M	291.58M	355.17M	335.96M	315.64M	294.65M	645.29M
Invested Capital (Quarter)					190.00M	181.33M	172.16M	160.30M	148.72M	137.22M	183.69M	276.94M	287.68M	274.15M	258.43M	255.37M	236.72M	218.68M	364.47M	345.87M	326.04M	305.23M	284.07M	1,006.52M
Leverage & Solvency
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)					0.95	0.96	0.96	0.95	0.95	0.95	0.95	0.96	0.95	0.95	0.95	0.95	0.96	0.95	0.96	0.95	0.96	0.95	0.94	0.98
Valuation
Enterprise Value (Quarter)					-195.58M	-185.08M	-177.20M	-165.98M	-151.27M	-139.81M	-187.29M	-162.91M	-282.58M	-285.60M	-266.60M	-263.44M	-240.65M	-225.30M	-250.88M	-358.16M	-305.55M	-315.44M	-271.53M	-995.02M
Return Ratios
Return on Capital Employed (Quarter)					-29.77%	-22.16%	-25.27%	-29.83%	-32.26%	-37.07%	-36.64%	-26.81%	-24.70%	-26.10%	-31.95%	-34.85%	-36.48%	-41.97%	-29.95%	0.12%	-0.33%	-0.78%	-1.75%	-14.78%
Return on Invested Capital (Quarter)					-0.01%	0.00%	0.00%	0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)					0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)					-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%